FindTrial
Sign In

This study is designed to look at certain blood parameters like biomarkers for predicting the outcome of COVID patients

Role of Biomarkers and itâ??s trend to predict the outcome of COVID patients, retrospective review

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028436
Enrollment
130
Registered
2020-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Amarja Havaldar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with COVID 19 pneumonia admitted in ICU

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To study the trend of biomarkers and itâ??s effect on outcome (ICU mortality)in patients admitted with the diagnosis of COVID pneumonia.Timepoint: ICU mortality or at the end of 4 weeks Hospital mortality or at the end of 90 days—

Secondary

MeasureTime frame
1.To study the number of ventilator free days 2. To study the difference in ICU length of stay Timepoint: ICU mortality or at 4 weeks—

Countries

India

Contacts

Public ContactDr Amarja Havaldar

St Johns Medical college

amarjahavaldar@rediffmail.com9036082112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026